SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

US investment network targets European health & wellness firms

By Nicola Cottam , 01-Apr-2014

NCN: “We have reached a critical mass of strategic investor members of NCN in the supply and specialty nutrient business and believe this is a good time to expand our network into Europe.”
NCN: “We have reached a critical mass of strategic investor members of NCN in the supply and specialty nutrient business and believe this is a good time to expand our network into Europe.”

Nutrition Capital Network (NCN) is setting up shop in Europe this May at Vitafoods in Geneva and is scouting for investment opportunities in the health and wellness sector.

Launched in 2007 in San Diego, Califronia, NCN acts as a mediator between businesses and investors having already secured financing for 166 companies through 19 host meetings over the last five years.

Key investors in the include BASF, Bayer, Cargill, Coca-Cola, DSM, DuPont, Hershey’s, Kellogg’s, Pepsi, Tate & Lyle and Unilever.

NCN president, Grant Ferrier said: “Interest in nutrition and health and wellness is a global trend; given the consistent quality and volume of deal flow we have seen over the last several years.

We have reached a critical mass of strategic investor members of NCN in the supply and specialty nutrient business and believe this is a good time to expand our network into Europe.”

The focus of NCN Europe will be on science, technology and value-added suppliers, with up to 12 presenting companies and 40 potential investors, including Abbott Labs, DSM, Cargill, Herbalife, Nestle Health Sciences, Kerry Group, Unilever, Novus, Seventure and Tate & Lyle Ventures.

Broad range of opportunities

Of particular interest to investors is technology and innovation targeting health conditions in brain function and memory; diabetes and weight loss; energy; digestive distress, the human biome, probiotics, heart health and micronutrients, and diagnostic and monitoring equipment to support the development of personalized medicine.

Ferrier explained: “Investors are looking to make equity investments or acquisitions, but equally important, seeking to develop leads or their corporate partnerships in technology development, commercialisation, clinical trials, distribution or licensing.

“Innovation is very much an internal and external thing in the corporate toolkit these days, and NCN has become part of that for many of our investor members.”

Presenting companies need to be organised, have a focused plan, be motivated, have a good track record, as well as solid intellectual property (IP) testing behind their science.

Ferrier added: “Some pre-commercial firms have millions in development behind them from grants or university work and have some value. In the end equity investors invest in solid business propositions but strategic investors may be more interested in IP with high potential in their areas of interest.”

The half-day meeting is scheduled for May 5, from 12-6pm, prior to the Vitafoods Europe exhibition and conference.

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars